Package Leaflet: Information for the User
Avaric 67micrograms sublingual tablets
Avaric 133micrograms sublingual tablets
Avaric 267micrograms sublingual tablets
Avaric 400micrograms sublingual tablets
Avaric 533micrograms sublingual tablets
Avaric 800micrograms sublingual tablets
fentanyl
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Avaric contains the active substance fentanyl, which belongs to a group of strong pain-relieving medicines called opioids.
Avaric is used to treat breakthrough pain in adult patients with cancer who are already taking other opioid pain medicines for their persistent (ongoing) pain.
Breakthrough pain is a type of pain that occurs suddenly, even when you have taken your usual opioid pain medicine for your persistent pain.
Do not takeAvaric
Warnings and precautions
Avaric contains an active substance in a quantity that can be fatal for a child. Therefore, always keep all tablets out of the sight and reach of children and those who are not patients.
Keep the tablets in a locked cupboard and do not store the tablets once they have been removed from the blister pack.
Consult your doctor or pharmacist before starting to take Avaric.
Keep this medicine in a safe place where others cannot get to it (see section 5. Storing Avaric for more information).
Before starting treatment, inform your doctor if you have or have had any of the following symptoms, as they will need to be taken into account when prescribing your dose:
While taking Avaric, consult your doctor if:
This medicine contains fentanyl, which is an opioid. It can cause dependence and/or addiction. |
Respiratory sleep disorders
Avaric can cause respiratory sleep disorders, including sleep apnea (interrupted breathing while sleeping) and sleep hypoxemia (low oxygen levels in the blood). Symptoms may include interrupted breathing while sleeping, waking up in the middle of the night due to lack of air, difficulty staying asleep, or excessive sleepiness during the day. If you or someone else observes these symptoms, contact your doctor to assess the possibility of reducing the dose.
Children and adolescents
Avaric must not be used in children and adolescents under 18 years of age.
Using Avaric with other medicines
Tell your doctor or pharmacist that you are taking, have recently taken, or might take any other medicines. In particular:
However, if your doctor prescribes Avaric together with sedative medicines, your doctor must limit the dose and duration of concomitant treatment. Inform your doctor about all sedative medicines you are taking and closely follow your doctor's recommendations. It may be useful to inform friends or family members who are aware of the signs and symptoms indicated above. Contact your doctor when you experience such symptoms.
Taking Avaric with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not use Avaric if you are pregnant, unless you have discussed it with your doctor. You should not use Avaric during labor, as fentanyl can cause respiratory depression and withdrawal syndrome in the fetus or newborn.
Fentanyl can pass into breast milk and cause side effects in the breastfed baby. Do not use Avaric if you are breastfeeding. You should not start breastfeeding until at least 5 days after the last dose of Avaric.
Driving and using machines
Ask your doctor if it is safe for you to drive or use machines after taking Avaric. You should not drive or use machines if you feel drowsy or dizzy, have blurred or double vision, or experience difficulty concentrating. It is important that you know how you react to Avaric before driving or using machinery.
Avaric contains sodium
This medicine contains less than 1 mmol of sodium per tablet, which is essentially “sodium-free”.
Before starting treatment and on a regular basis during treatment, your doctor will also explain what you can expect from using Avaric, when and for how long you should use it, when you should contact your doctor, and when you should stop using it (see also section 2).
This medication should be taken by placing the tablet under the tongue (sublingual use).
Follow your doctor's or pharmacist's administration instructions for this medication exactly. If in doubt, consult your doctor or pharmacist again.
If your doctor has switched you to Avaric, do not use the previous medication containing fentanyl for breakthrough pain treatment at the same time. Dispose of the previous medication. However, continue using the opioid medication you are using for persistent cancer pain during treatment with Avaric.
Initial phase – Establishing the most suitable dose
For treatment with Avaric to be successful, your doctor will need to identify the most suitable dose for treating breakthrough pain. Avaric is available in a wide range of doses. You may need to try different doses of Avaric during different episodes of pain before finding the most suitable dose. Your doctor will help you with this task and find the most suitable tablet dose for you.
If you do not get adequate pain relief with one tablet, your doctor may instruct you to take two tablets to treat a breakthrough pain episode. Do not take a second tablet unless your doctor instructs you to do so, as you may experience an overdose. Your doctor will advise you on the tablet dose to use.
You should always use the Avaric dose prescribed by your doctor –this may be different from the dose you used with other medications to treat breakthrough pain.
Maintenance phase – Once the most suitable dose has been established
Once you and your doctor have established an Avaric dose that controls your breakthrough pain, you should not take this dose more than four times a day. A dose of Avaricmay consist of more than one tablet.
If you think the Avaric dose you are using does not control your breakthrough pain satisfactorily, inform your doctor, as you may need to have your dose adjusted.
Do not change your Avaric dose unless your doctor instructs you to do so.
Taking the medication
Avaric should be used sublingually. This means that the tablet should be placed under the tongue, where it will dissolve quickly to allow fentanyl to be absorbed through the lining of the mouth.
When you have a breakthrough pain episode, take the dose indicated by your doctor as follows:
If you take more Avaric than you should
The symptoms of an overdose include altered mental state, loss of consciousness, extreme drowsiness, slow, shallow breathing. If this happens, seek medical help immediately.
An overdose can also cause a brain disorder known as toxic leukoencephalopathy.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Note for caregivers
While waiting for the doctor:
If you think someone has taken Avaric accidentally, seek immediate emergency medical help.
If you forget to take Avaric
Do not take a double dose to make up for forgotten doses.
If you stop treatment with Avaric
You should stop using Avaric when you no longer have breakthrough pain. However, you should continue taking your usual opioid medications for persistent cancer pain as recommended by your doctor. You may experience withdrawal symptoms similar to the possible side effects of Avaric when you stop treatment with Avaric. If you have withdrawal symptoms or are concerned about pain relief, consult your doctor, who will assess whether you need any medication to reduce or suppress withdrawal symptoms.
If you have any further questions about using this medication, ask your doctor or pharmacist.
Like all medications, Avaric can cause side effects, although not everyone will experience them.
The most serious side effects are:
If you start to feel drowsy or experience any of the above side effects, stop taking Avaric and contact your doctor immediately, or have your caregiver contact your doctor and call for emergency services.
Other side effects that may occur:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Frequency not known(cannot be estimated from available data):
Prolonged treatment with fentanyl during pregnancy may cause withdrawal symptoms in the newborn, which can be potentially life-threatening (see section 2).
Reporting side effects:
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's online system: https://www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medication.
The pain medication Avaric is very strong and can be fatal if a child takes it accidentally.
Keep this medication out of sight and reach of children.
Store this medication in a safe place where others cannot access it. It can cause serious harm and be fatal for people who take this medication accidentally or intentionally when it has not been prescribed for them.
Keep Avaric in a locked cabinet.
Do not use this medication after the expiration date shown on the carton after EXP. The expiration date is the last day of the month indicated.
This medication does not require special temperature storage conditions.
Store in the original blister pack to protect from light.
Do not store the tablet once it has been removed from the blister pack.
Medications should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to the pharmacy's SIGRE collection point. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Avaric composition
Each sublingual tablet contains 67, 133, 267, 400, 533, or 800 micrograms of fentanyl (as citrate).
Appearance of the product and package contents
Avaric 67 micrograms is a white, convex, triangular tablet. Its height is 5.6 mm, and it has a "0" printed with black ink on one side.
Avaric 133 micrograms is a white, convex, triangular tablet. Its height is 5.6 mm, and it has a "1" printed with black ink on one side.
Avaric 267 micrograms is a white, convex, triangular tablet. Its height is 5.6 mm, and it has a "2" printed with black ink on one side.
Avaric 400 micrograms is a white, convex, triangular tablet. Its height is 5.6 mm, and it has a "4" printed with black ink on one side.
Avaric 533 micrograms is a white, convex, triangular tablet. Its height is 5.6 mm, and it has a "5" printed with black ink on one side.
Avaric 800 micrograms is a white, convex, triangular tablet. Its height is 5.6 mm, and it has an "8" printed with black ink on one side.
Avaric sublingual tablets are available in child-resistant blister packs of 3, 4, 15, or 30 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
ANGELINI PHARMA ESPAÑA, S.L.
c/ Antonio Machado, 78-80.
3rd floor, module A-Australia Building
08840 Viladecans, Barcelona (Spain)
Manufacturer
Ethypharm
Chemin de la Poudrière
76120 Grand Quevilly
FRANCE
Acraf, S.P.A. (ACR ANGELINI FRANCESCO)
Via Vecchia del Pinocchio, 22
ANCONA, I-60131 - ITALY
This medication is authorized in the Member States of the European Economic Area under the following names:
Sweden: Vellofent
Bulgaria: Vellofent
Czech Republic: Vellofent
Spain: Avaric
Greece: Vellofent
Italy: Vellofent
Poland: Vellofent
Portugal: Vellofent
Date of last revision of thisleaflet:March 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
The average price of AVARIC 267 micrograms SUBLINGUAL TABLETS in October, 2025 is around 49.52 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.